Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Arginase Inhibition and Endothelial Function in Humans With Obesity

NCT05536934 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT05536934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05536934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Arginase Inhibition and Endothelial Function in Humans With Obesity
Lead sponsor
Karolinska Institutet
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2016
Completion date
March 31, 2022
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endothelial function, obese